A detailed history of Northwest Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Northwest Wealth Management, LLC holds 1,071 shares of LLY stock, worth $799,180. This represents 0.22% of its overall portfolio holdings.

Number of Shares
1,071
Previous 1,088 1.56%
Holding current value
$799,180
Previous $985,000 3.76%
% of portfolio
0.22%
Previous 0.26%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$772.14 - $960.02 $13,126 - $16,320
-17 Reduced 1.56%
1,071 $948,000
Q2 2024

Aug 05, 2024

BUY
$724.87 - $909.04 $11,597 - $14,544
16 Added 1.49%
1,088 $985,000
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $104,819 - $140,233
177 Added 19.78%
1,072 $833,000
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $110,815 - $130,636
211 Added 30.85%
895 $521,000
Q3 2023

Nov 01, 2023

SELL
$434.7 - $599.3 $1,304 - $1,797
-3 Reduced 0.44%
684 $367,000
Q2 2023

Aug 07, 2023

SELL
$350.74 - $468.98 $11,574 - $15,476
-33 Reduced 4.58%
687 $322,000
Q1 2023

May 10, 2023

SELL
$310.63 - $364.82 $11,803 - $13,863
-38 Reduced 5.01%
720 $247,000
Q4 2022

Feb 07, 2023

SELL
$321.55 - $374.67 $127,655 - $148,743
-397 Reduced 34.37%
758 $277,000
Q3 2022

Oct 27, 2022

BUY
$296.48 - $337.87 $26,386 - $30,070
89 Added 8.35%
1,155 $373,000
Q2 2022

Jul 26, 2022

BUY
$278.73 - $327.27 $44,039 - $51,708
158 Added 17.4%
1,066 $346,000
Q1 2022

Apr 29, 2022

BUY
$234.69 - $291.66 $28,162 - $34,999
120 Added 15.23%
908 $260,000
Q4 2021

Jan 24, 2022

BUY
$224.85 - $279.04 $177,181 - $219,883
788 New
788 $218,000
Q2 2019

Jul 23, 2019

SELL
$110.79 - $129.32 $103,588 - $120,914
-935 Closed
0 $0
Q1 2018

Apr 13, 2018

BUY
$74.21 - $87.6 $69,386 - $81,906
935 New
935 $72,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Northwest Wealth Management, LLC Portfolio

Follow Northwest Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Wealth Management, LLC with notifications on news.